| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77efb158eb15ed253fe3bfdc80a16f3b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-08 |
| filingDate |
2012-11-27^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3ed03fbb72ff25a5e495aa8ec0dd111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce1e70c247a1ab0e56773eb88ea96ce2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8a8d8d63d690c22384f810474975157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a23b0d4068a4244306c8d6d7fc4ef3fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49383e4f8952a8ea82029451573c306b |
| publicationDate |
2013-03-28^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013079283-A1 |
| titleOfInvention |
Erythropoitein Receptor Peptide Formulations and Uses |
| abstract |
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, and dosages are also provided. |
| priorityDate |
2005-06-03^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |